Catalyst Wire Dossier Catalyst Wire Dossier

Noex® 32µg

· Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Noex® 32µg, covering 2019-10-09 to 2019-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis [Phase 3]

See pricing